Activities of Kay SWINBURNE related to 2014/2207(INI)
Plenary speeches (1)
Safer healthcare in Europe (A8-0142/2015 - Piernicola Pedicini)
Amendments (27)
Amendment 16 #
Motion for a resolution
Recital E
Recital E
E. whereas the current economic crisis is having a direct impact on patient safety, as manyhas placed increased pressure on Member States have reducedealthcare budgets and staffing levels in their healthcare systemsthis can have an impact on patient safety;
Amendment 29 #
Motion for a resolution
Recital H
Recital H
Amendment 61 #
Motion for a resolution
Recital O
Recital O
O. whereas resistance to antibiotics for certain bacteria is at least 25 % or more in several Member States; whereas antibiotic resistance is spreading much faster than the introduction of new antibiotics into clinical practicethere is a growing gap between the increase in antimicrobial resistance and the development of new antimicrobials;
Amendment 80 #
Motion for a resolution
Recital Q
Recital Q
Q. whereas it is of paramount importance to encourage pharmaceutical companies to invest in developing new antibiotic compounds, in particular with activity against prevalent multidrug-resistant Gram-negative bacteria such as K. pneumoniae and Acinetobacter and to address some of the key scientific, regulatory and economic challenges that have hampered antibiotic development and contributed to the lack of investment;
Amendment 90 #
Motion for a resolution
Recital R
Recital R
R. whereas it is vital to ensure patients’ rights and public confidence in health services, by ensuring Member States have in place systems to providinge fair financial compensation in the case of adverse eventsnegligence arising from faulty medical provision;
Amendment 108 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Notes, however, that the second implementation report still shows uneven progress among Member States on patient safety, and regrets the fact that some Member States have obviously slowed down implementation of the Council recommendations becaus, possibly as a consequence of financial constraints resulting from the economic crisis;
Amendment 110 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Calls on Member States to make sure that the healthcare system is not affected by austerity measures and to ensure a sufficient number of healthcare professionals specialised in infection prevention and control, as well as hospital hygienes are adequately funded and to ensure consistent good practice throughout healthcare systems, by educating and training all healthcare professionals in hygiene and infection control and ensuring a sufficient number of specialised infection control staff for a more patient-centred approach;
Amendment 125 #
Motion for a resolution
Paragraph 6 – point c
Paragraph 6 – point c
c) ensure appropriate and up-to-date training of doctors and other healthcare professionals and set up monitoring systems to verify that their competences are up-to-date within order to keep pace with the latest and best hospital hygiene practices and the technology in place;
Amendment 153 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Notes that patient safety is not widely embedded in the undergraduate education of healthcare workers, nor in on-the-job- training or the continuing training of health professionals in all Member States;
Amendment 170 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Encourages the Member States to set up independent bodies to liaise with professionals when reporting on healthcare facility failures having an impact onin order to ensure the raising of awareness and the dissemination of alerts regarding threats to patient safety;
Amendment 172 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Invites the Member States to be more rigorous in verifying and enforcing the ban on non-medical external staff performing medical treatment; points out that this is happening with employees of companies that provide sophisticated medical machinery to hospitals; therefore, calls on Member States to introduce a mandatory registration of the presence of product specialists during therapeutic treatments;
Amendment 177 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Calls on the Member States to provide for collective redress mechanisms in their national law so as to allow the introduction of fair compensation systems forensure that full information on existing mechanisms for complaint and redress is readily available to patients who have suffered an HAI or a medical error;
Amendment 179 #
Motion for a resolution
Paragraph 14
Paragraph 14
Amendment 181 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Invites the Commission to report on national practices of collective redress in HAI-related cases and to launch a consultation aimed at debating the possibility of harmonising collective redress in HAI cases at European level;
Amendment 204 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
19a. Calls on the Commission and the Member States to strengthen incentives for public and private sector cooperation to reinvigorate antibiotic development R&D;
Amendment 207 #
Motion for a resolution
Paragraph 19 b (new)
Paragraph 19 b (new)
19b. Urges, in this regard, reform and harmonisation of regulatory regimes regarding the licensing and approval of antibiotics, in such a way as to encourage rather than stifle innovation and research in this field;
Amendment 209 #
Motion for a resolution
Paragraph 19 c (new)
Paragraph 19 c (new)
19c. Highlights the important role preventative immunisation programmes can play in limiting the use of antibiotics and thereby the development of antimicrobial resistance;
Amendment 234 #
Motion for a resolution
Paragraph 22 – point a
Paragraph 22 – point a
a) regulatemind physicians of the paramount importance of ensuring that the prescription of antibiotics for treatment or prophylaxis iso that an appropriate use of medicines is ensured,and responsible, recalls, in this regard, the trust that patients place in their doctors in specifying the therapeutic objective and selecting the appropriate drug therapy;
Amendment 241 #
Motion for a resolution
Paragraph 22 – point b
Paragraph 22 – point b
b) regulate the sale of antibiotics soensure that patients can buyreceive only the specific quantity of antibiotics as prescribed by their doctors;
Amendment 249 #
Motion for a resolution
Paragraph 22 – point c
Paragraph 22 – point c
c) ensure patients’greater levels of adherence to and compliance with antibiotic treatments as prescribed by medical professionals, amongst patients by increasing patient understanding of the importance of responsible use of antibiotic treatments and the risks of increasing antimicrobial resistance;
Amendment 250 #
Motion for a resolution
Paragraph 22 – point d
Paragraph 22 – point d
d) ensure that antibiotics arewhen used in hospitals onlyare only used for the correct indications, at the correct dose and for the shortest duration possible as recommended by evidence-based guidelines;
Amendment 252 #
Motion for a resolution
Paragraph 22 – point e
Paragraph 22 – point e
e) intensify infection control, in particular from a cross-border perspective, by properly screening patients transferred from a country/by encouraging guidance on screening and isolation of patients on admission to hospital if they have pregvion/hospital known for its high prevalence of multidrug-resistant bacteriausly been hospitalised in countries where very resistant infections are more prevalent;
Amendment 274 #
Motion for a resolution
Paragraph 23 – introductory part
Paragraph 23 – introductory part
23. Calls on theUrges Member States to introduce or develop the following measures:
Amendment 284 #
Motion for a resolution
Paragraph 23 – point b
Paragraph 23 – point b
b) Introduce, on the basis of sound scientific evidence and in conjunction with advice from relevant experts, legal tools to restrict the use of antibiotics in animals if a significant risk to public health is identified;
Amendment 300 #
Motion for a resolution
Paragraph 24
Paragraph 24
24. Urges the Member States to regulate, where they exist, any conflicts of interest involving veterinarians who both sell and prescribe antibiotics;
Amendment 307 #
Motion for a resolution
Paragraph 25 – indent 1
Paragraph 25 – indent 1
– to adoptconsider provisions aimed at banning or limiting the off- label use in animals of certain antimicrobials authorised only in human medicine, following a risk assessment of such use;
Amendment 312 #
Motion for a resolution
Paragraph 25 – indent 2
Paragraph 25 – indent 2
– to seek clarification of the impact of any proposal to introduce the mandatory registration of all off-label antimicrobials by prescribers of veterinary medicines as well as by the competent national authorities;